These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34247153)

  • 21. Thrombolysis, time-to-treatment and in-hospital outcomes among young adults with ischaemic stroke in China: findings from a nationwide registry study in China.
    Wang HY; Gu HQ; Zhou Q; Jiang YY; Yang X; Wang CJ; Zhao XQ; Wang YL; Liu LP; Meng X; Li H; Liu C; Li ZX; Wang YJ; Jiang Y
    BMJ Open; 2022 Jun; 12(6):e055055. PubMed ID: 35750455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors.
    Van Schaik SM; Scott S; de Lau LM; Van den Berg-Vos RM; Kruyt ND
    Cerebrovasc Dis Extra; 2015; 5(2):75-83. PubMed ID: 26265910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated with Pre-Hospital Delay and Intravenous Thrombolysis in China.
    Zhu Y; Zhang X; You S; Cao X; Wang X; Gong W; Qin Y; Huang X; Cao Y; Shi R
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104897. PubMed ID: 32430238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stroke pathway performance assessment: a retrospective observational study.
    Camporesi J; Strumia S; Di Pilla A; Paolucci M; Orsini D; Assorgi C; Cacciuttolo MG; Specchia ML
    BMC Health Serv Res; 2023 Dec; 23(1):1391. PubMed ID: 38082226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in-hospital stroke system to optimize emergency management of acute ischemic stroke by reducing door-to-needle time.
    Zhang Y; Zhu Y; Jiang T; Liu J; Tang X; Yi W
    Am J Emerg Med; 2023 Jul; 69():147-153. PubMed ID: 37119700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generalization of the right acute stroke promotive strategies in reducing delays of intravenous thrombolysis for acute ischemic stroke: A meta-analysis.
    Huang Q; Zhang JZ; Xu WD; Wu J
    Medicine (Baltimore); 2018 Jun; 97(25):e11205. PubMed ID: 29924046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit.
    Kuhrij LS; Marang-van de Mheen PJ; van den Berg-Vos RM; de Leeuw FE; Nederkoorn PJ;
    BMC Neurol; 2019 Nov; 19(1):265. PubMed ID: 31684901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke Care in the First Affiliated Hospital of Chengdu Medical College during the COVID-19 Outbreak.
    Zhang LL; Guo YJ; Lin YP; Hu RZ; Yu JP; Yang J; Wang X
    Eur Neurol; 2020; 83(6):630-635. PubMed ID: 33341815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determinants of door to needle time for intravenous thrombolysis in acute ischemic stroke].
    Brunser AM; Mazzon E; Muñoz P; Hoppe A; Lavados PM; Rojo A; Navia V; Cavada G; Olavarría VV; Mansilla E
    Rev Med Chil; 2020 Aug; 148(8):1090-1095. PubMed ID: 33399775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
    Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors for symptomatic intracranial hemorrhage after intravenous thrombolysis with acute ischemic stroke within 6 h in northern China: a multicenter, retrospective study.
    Xue Y; Li S; Xiang Y; Wang Z; Wang F; Yu Y; Yan P; Liu X; Sun Q; Du Y; Li J
    BMC Neurol; 2022 Jan; 22(1):6. PubMed ID: 34980004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the COVID-19 outbreak on acute stroke care in Slovakia: Data from across the country.
    Gdovinová Z; Vitková M; Baráková A; Cvopová A
    Eur J Neurol; 2021 Oct; 28(10):3263-3266. PubMed ID: 33185918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal Trends in Clinical Characteristics and Door-to-Needle Time in Patients Receiving Intravenous Tissue Plasminogen Activator: A Retrospective Study of 4 Hospitals in Japan.
    Tanaka K; Matsumoto S; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104305. PubMed ID: 31405791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous thrombolysis for acute ischaemic stroke during COVID-19 pandemic in Wuhan, China: a multicentre, retrospective cohort study.
    Zhou Y; Hong C; Chang J; Xia Y; Jin H; Li Y; Mao L; Wang Y; Zhang L; Pan C; Hu J; Huang M; Wang D; Chen S; Hu B
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):226-228. PubMed ID: 33115934
    [No Abstract]   [Full Text] [Related]  

  • 36. A full year of the COVID-19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany.
    Richter D; Eyding J; Weber R; Bartig D; Grau A; Hacke W; Krogias C
    Eur J Neurol; 2022 Jan; 29(1):105-113. PubMed ID: 34370900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a code stroke protocol on the door-to-needle time for IV thrombolysis: a feasibility study.
    Vanhoucke J; Hemelsoet D; Achten E; De Herdt V; Acou M; Vereecke E; Hachimi-Idrissi S
    Acta Clin Belg; 2020 Aug; 75(4):267-274. PubMed ID: 31081471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic.
    Jasne AS; Chojecka P; Maran I; Mageid R; Eldokmak M; Zhang Q; Nystrom K; Vlieks K; Askenase M; Petersen N; Falcone GJ; Wira CR; Lleva P; Zeevi N; Narula R; Amin H; Navaratnam D; Loomis C; Hwang DY; Schindler J; Hebert R; Matouk C; Krumholz HM; Spudich S; Sheth KN; Sansing LH; Sharma R
    Stroke; 2020 Sep; 51(9):2664-2673. PubMed ID: 32755347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three easily-implementable changes reduce median door-to-needle time for intravenous thrombolysis by 23 minutes.
    Tran D; Zhu Z; Shafie M; Abcede H; Stradling D; Yu W
    BMC Neurol; 2019 Nov; 19(1):300. PubMed ID: 31771530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome After Acute Ischemic Stroke Treatment During Covid-19 Outbreak in South-East Tuscany.
    Acampa M; Peresso V; Lazzerini PE; Domenichelli C; Guideri F; Tassi R; Dami S; Marconi R; Iannelli G; Linoli G; Peppoloni G; Nocentini S; Gallerini S; Cartocci A; Bracco S; Martini G
    Cardiovasc Hematol Disord Drug Targets; 2021; 21(3):179-184. PubMed ID: 34579640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.